2026/0002 - FOSLEVODOPA + FOSCARBIDOPA [240 + 12 MG/ML SOL INJ FRS]
TED · 635497-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 26 | — | 2026-09-15 |
| GILEAD SCIENCES, LDA | 24 | — | 2026-09-15 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 20 | €1,569,649 | 2026-09-15 |
| JANSSEN-CILAG FARMACEUTICA LDA | 15 | €371,730 | 2026-09-15 |
| NOVARTIS FARMA - PROD.FARM SA | 14 | — | 2026-09-08 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
FOSLEVODOPA + FOSCARBIDOPA [240 + 12 MG/ML SOL INJ FRS]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-15 | 2026/0002 - FOSLEVODOPA + FOSCARBIDOPA [240 + 12 MG/ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-07-21 | 2026/0002 - LEVODOPA + CARBIDOPA [20 MG/ML + 5 MG/ML GEL INTEST SACO] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-09-09 | C/ base no CPA 2023_671 - Foslevodopa 240 mg/ml + Foscarbidopa 12 mg/ml sol inj fr 10 ml sc | Unidade Local de Saúde de Coimbra, EPE PT | 94% |
| 2026-08-04 | 2026/0002 - NUSINERSEN [12 MG/5 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 94% |
| 2026-07-07 | 2025/1303 - ISATUXIMAB [20 MG/ML 25 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |
| 2026-07-14 | 2023/0481 - SACITUZUMAB GOVITECANO [200 MG PÓ CONC SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 93% |